BackOncoCyte Overview

OncoCyte Total Current Liabilities

Track OncoCyte's total current liabilities ($10M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$10.29M
54.63% YoYΔ $3.63M vs prior year quarter

Peer trimmed avg / median

Loading

OncoCyte Total Current Liabilities History

Loading

OncoCyte vs. peers: Total Current Liabilities Comparison

Loading

OncoCyte Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

OncoCyte (0KCC.L) FAQ

The latest total current liabilities for 0KCC.L is $10M as of June 2026. That compares with $6.7M in the prior-year period — up 54.6% year over year. Investors often review this figure alongside OncoCyte's historical trend and sector peers before judging valuation or financial health.

Over the past year, 0KCC.L's total current liabilities moved from $6.7M to $10M — a 54.6% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in OncoCyte's operating scale or balance-sheet position.

A total current liabilities figure of $10M for 0KCC.L is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting 0KCC.L's total current liabilities ($10M), review year-over-year change from $6.7M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.